HomeNAV • CVE
add
Navco Pharmaceuticals Inc
Previous close
$0.0050
Year range
$0.0050 - $0.010
Market cap
285.35K CAD
Avg Volume
24.74K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.06K | -71.07% |
Net income | -5.83K | 44.16% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 807.00 | -41.52% |
Total assets | 807.00 | -98.57% |
Total liabilities | 942.81K | 2.10% |
Total equity | -942.01K | — |
Shares outstanding | 57.07M | — |
Price to book | -0.25 | — |
Return on assets | -270.89% | — |
Return on capital | 0.60% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -5.83K | 44.16% |
Cash from operations | -2.18K | -122.93% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -2.18K | 63.52% |
Free cash flow | 735.00 | -76.77% |
About
Headquarters
Website
